Published in Am J Pathol on September 01, 2000
Melanoma: from mutations to medicine. Genes Dev (2012) 2.59
Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo. J Invest Dermatol (2007) 2.11
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun (2014) 2.00
A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol (2012) 1.57
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res (2013) 1.56
The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol (2014) 1.22
NRAS mutant melanoma: biological behavior and future strategies for therapeutic management. Oncogene (2012) 1.15
Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. J Invest Dermatol (2008) 1.03
My approach to atypical melanocytic lesions. J Clin Pathol (2004) 0.98
Genetics and genomics of melanoma. Expert Rev Dermatol (2009) 0.98
Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications. J Carcinog (2010) 0.97
Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas. Am J Dermatopathol (2012) 0.97
Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. Am J Pathol (2004) 0.97
Molecular nevogenesis. Dermatol Res Pract (2011) 0.97
Spitz nevi and other Spitzoid lesions part I. Background and diagnoses. J Am Acad Dermatol (2011) 0.96
Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions. Am J Surg Pathol (2014) 0.96
Evaluation of the clonal origin of multiple primary melanomas using molecular profiling. J Invest Dermatol (2009) 0.96
The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. J Am Acad Dermatol (2012) 0.96
Rare presentations of primary melanoma and special populations: a systematic review. Am J Clin Oncol (2014) 0.92
Genetics of melanoma. Front Genet (2013) 0.91
Targeted therapy for melanoma: a primer. Surg Oncol Clin N Am (2011) 0.89
A case of spitzoid melanoma with lymph node metastasis in a child. J Korean Med Sci (2012) 0.88
Molecular-microscopical correlation in dermatopathology. J Cutan Pathol (2011) 0.87
Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms. Int J Clin Exp Pathol (2010) 0.87
Applications of genomics in melanoma oncogene discovery. Hematol Oncol Clin North Am (2009) 0.87
Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions. Am J Surg Pathol (2015) 0.85
Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells. Arch Pathol Lab Med (2010) 0.84
Growth factors and oncogenes as targets in melanoma: lost in translation? Adv Dermatol (2007) 0.83
Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition. Oncogene (2013) 0.82
Genetics of melanocytic nevi. Pigment Cell Melanoma Res (2015) 0.81
Desmoplastic melanoma with sarcomatoid dedifferentiation. Am J Surg Pathol (2014) 0.80
Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation. Am J Surg Pathol (2016) 0.79
Cooperativity of Cdk4R24C and Ras in melanoma development. Cell Cycle (2010) 0.79
Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. Pathology (2016) 0.79
[DNA copy number changes in the diagnosis of melanocytic tumors]. Pathologe (2007) 0.78
Long-term outcome of Spitz-type melanocytic tumors. Arch Dermatol (2011) 0.77
Update on Molecular Pathology of Cutaneous Melanocytic Lesions: What is New in Diagnosis and Molecular Testing for Treatment? Front Med (Lausanne) (2014) 0.77
Differentiation of pigmented Spitz nevi and Reed nevi by integration of dermatopathologic and dermatoscopic findings. Dermatol Pract Concept (2012) 0.76
Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer. Ther Adv Med Oncol (2015) 0.76
Fluorescence in situ hybridization testing of chromosomes 6, 8, 9 and 11 in melanocytic tumors is difficult to automate and reveals tumor heterogeneity in melanomas. Oncol Lett (2016) 0.75
Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus. Mod Pathol (2016) 0.75
Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas. Mod Pathol (2017) 0.75
Recent advances in molecular genetics of melanoma progression: implications for diagnosis and treatment. F1000Res (2016) 0.75
Identification of recurrent mutational events in anorectal melanoma. Mod Pathol (2016) 0.75
A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment. Mod Pathol (2016) 0.75
[Morphological and genetic aspects of Spitz tumors]. Pathologe (2015) 0.75
Diagnostic role of chromosomal instability in melanoma. J Skin Cancer (2012) 0.75
Melanocytic nevi and melanoma: unraveling a complex relationship. Oncogene (2017) 0.75
NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report. Virchows Arch (2014) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
Genetic instabilities in human cancers. Nature (1998) 22.76
ras genes. Annu Rev Biochem (1987) 22.59
Melanomas of childhood. Am J Pathol (1948) 7.99
Mutator phenotype may be required for multistage carcinogenesis. Cancer Res (1991) 7.29
A matter of life and cell death. Science (1998) 5.33
Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol (1996) 3.59
Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci U S A (1982) 3.48
Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res (1989) 3.35
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol (1999) 2.50
Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res (1998) 2.44
Ras1 promotes cellular growth in the Drosophila wing. Cell (2000) 2.42
Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science (1986) 2.33
ras gene Amplification and malignant transformation. Mol Cell Biol (1985) 2.02
Spitz nevi. J Am Acad Dermatol (1992) 1.77
Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res (2000) 1.67
The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci (1998) 1.59
Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc Natl Acad Sci U S A (1985) 1.43
Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol (1999) 1.39
Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol (1996) 1.36
A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. Nucleic Acids Res (1986) 1.33
H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int J Cancer (2000) 1.15
N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol (1998) 1.15
Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. J Am Acad Dermatol (1998) 1.09
Activated ras. Yet another player in melanoma? Am J Pathol (1996) 1.05
Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol (1994) 1.04
Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary. Cancer Res (1985) 1.02
Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype. Oncogene (1992) 1.00
Trisomy 12 and K-ras-2 amplification in human ovarian tumors. Int J Cancer (1991) 0.94
Allelotypes of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res (1996) 0.92
On the nature of histologic observations: the case of the Spitz nevus. J Am Acad Dermatol (1995) 0.91
Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects. Int J Cancer (1996) 0.89
Spitz naevi and malignant melanomas of childhood and adolescence. Histopathology (1986) 0.84
Melanoma resembling spindle and epithelioid cell nevus. Arch Dermatol (1979) 0.83
Eosinophilic globules in spitz nevi: no evidence for apoptosis. Am J Dermatopathol (1998) 0.80
Spitz nevi. J Am Acad Dermatol (1993) 0.79
Melanoma masquerading as Spitz nevus following acute lymphoblastic leukemia. Pediatr Dermatol (1984) 0.78
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (1992) 16.38
Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A (1986) 12.92
Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet (2001) 11.06
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet (1999) 6.18
The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell (1999) 6.08
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A (1994) 5.74
Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med (1992) 5.57
Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer (1994) 5.52
Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet (2001) 4.96
Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet (2000) 4.13
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci U S A (1992) 3.25
Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J (1998) 3.12
E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol (1997) 3.10
Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer (1971) 3.04
Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A (1998) 2.80
Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med (1997) 2.71
Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet (2000) 2.66
Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res (1998) 2.44
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev (1995) 2.41
The proximity of DNA sequences in interphase cell nuclei is correlated to genomic distance and permits ordering of cosmids spanning 250 kilobase pairs. Genomics (1989) 2.39
Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med (1999) 2.39
"Total therapy" studies of acute lymphocytic leukemia in children. Current results and prospects for cure. Cancer (1972) 2.28
Granuloma annulare and human immunodeficiency virus infection. Arch Dermatol (1999) 2.26
Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood (1971) 2.18
Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med (1993) 2.14
Segmentation of confocal microscope images of cell nuclei in thick tissue sections. J Microsc (1999) 2.12
Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol (1993) 2.09
The epidemiology of bacillary angiomatosis and bacillary peliosis. JAMA (1993) 2.03
Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med (1993) 1.99
Prevention of central nervous system leukemia by irradiation. Cancer (1973) 1.96
'Allogeneic marrow transplantation in children with acute leukemia: a practice whose time has gone': twenty years later. Leukemia (2009) 1.95
Nephrogenic fibrosing dermopathy. Am J Dermatopathol (2001) 1.91
Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res (1995) 1.91
Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science (1990) 1.90
BAC microarray analysis of 15q11-q13 rearrangements and the impact of segmental duplications. J Med Genet (2004) 1.87
Five-year follow-up of "total therapy" of childhood lymphocytic leukemia. JAMA (1971) 1.84
Overexpression of p53 tumor suppressor protein in porokeratosis. Arch Dermatol (1994) 1.82
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res (2000) 1.81
Computer image analysis of comparative genomic hybridization. Cytometry (1995) 1.80
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79
Cytogenetic analysis by in situ hybridization with fluorescently labeled nucleic acid probes. Cold Spring Harb Symp Quant Biol (1986) 1.77
Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol (2001) 1.73
The organism causing bacillary angiomatosis, peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med (1991) 1.72
Signet-ring cell formation in cutaneous neoplasms. J Am Acad Dermatol (1999) 1.69
Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res (2000) 1.67
Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res (1998) 1.61
Selecting treatment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 1.57
Cutaneous vascular lesions and disseminated cat-scratch disease in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med (1988) 1.56
Cessation of therapy during complete remission of childhood acute lymphocytic leukemia. N Engl J Med (1974) 1.55
Clinical applications of fluorescence in situ hybridization. Genet Anal Tech Appl (1991) 1.52
Cutaneous spindle-cell B-cell lymphoma: a morphologic variant of cutaneous large B-cell lymphoma. Am J Dermatopathol (2000) 1.52
Bacterial characterization by flow cytometry. Science (1983) 1.52
Lymphomatoid papulosis followed by Hodgkin's lymphoma. Differential response to therapy. Arch Dermatol (1993) 1.44
Microcystic adnexal carcinoma with extensive sebaceous differentiation. Am J Dermatopathol (1997) 1.44
Rapid translocation frequency analysis in humans decades after exposure to ionizing radiation. Int J Radiat Biol (1992) 1.43
Basal cell carcinoma with thickened basement membrane: a variant that resembles some benign adnexal neoplasms. Am J Dermatopathol (1997) 1.42
Fluorescence in situ hybridization to interphase cell nuclei in suspension allows flow cytometric analysis of chromosome content and microscopic analysis of nuclear organization. Hum Genet (1988) 1.41
Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. Am J Hum Genet (1991) 1.41
No worlds left to conquer? Am J Dermatopathol (2000) 1.41
A study of "total therapy" of acute lymphocytic leukemia in children. J Pediatr (1968) 1.40
Epithelial sheath neuroma: a new entity. Am J Surg Pathol (2000) 1.40
Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol (1999) 1.39
Dramatic tissue artifact that mimics morphea or scleroderma. J Am Acad Dermatol (1990) 1.39
Inflammatory nodule on the scalp. Pediatr Dermatol (1990) 1.37
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature. Oncogene (2007) 1.31
Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Cancer Res (1999) 1.30
Rapid human chromosome aberration analysis using fluorescence in situ hybridization. Int J Radiat Biol (1989) 1.28
Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study. Mod Pathol (2000) 1.26
Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. Cancer Res (1972) 1.25
Construction and characterization of plasmid libraries enriched in sequences from single human chromosomes. Genomics (1991) 1.25
A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis. Genomics (1995) 1.24
Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells. Mol Cell Endocrinol (2001) 1.22
The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol (1994) 1.20
Nine years' experience with "total therapy" of childhood acute lymphocytic leukemia. Pediatrics (1972) 1.17
Fryns syndrome phenotype caused by chromosome microdeletions at 15q26.2 and 8p23.1. J Med Genet (2005) 1.16
Lymphosarcoma, Hodgkin's disease and leukemia in bone. Clin Orthop Relat Res (1967) 1.16
Studies of murine leukemia viruses. I. Detection of Moloney and Rauscher leukemia viruses by indirect immunofluorescence. Proc Soc Exp Biol Med (1966) 1.14
Bacillary (epithelioid) angiomatosis and concurrent Kaposi's sarcoma in acquired immunodeficiency syndrome. Arch Dermatol (1989) 1.11
Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res (1992) 1.11
Therapy of localized and regional lymphosarcoma of childhood. Cancer (1971) 1.11
Fluorescence in situ hybridization to Y chromosomes in decondensed human sperm nuclei. Mol Reprod Dev (1990) 1.11
Analyses of brain tumor cell lines confirm a simple model of relationships among fluorescence in situ hybridization, DNA index, and comparative genomic hybridization. Genes Chromosomes Cancer (1997) 1.10
Measurement of sister chromatid exchanges at very low bromodeoxyuridine substitution levels using a monoclonal antibody in Chinese hamster ovary cells. Cancer Res (1985) 1.09
Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood (1998) 1.09
High resolution dual laser flow cytometry. J Histochem Cytochem (1978) 1.09
Fluorescence in situ hybridization with DNA probes. Methods Cell Biol (1990) 1.09
Flow karyotyping and sorting of human chromosomes. Cold Spring Harb Symp Quant Biol (1986) 1.09
Histologic features of cutaneous sinus histiocytosis (Rosai-Dorfman disease): study of cases both with and without systemic involvement. J Cutan Pathol (1992) 1.07
Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study. Clin Infect Dis (1996) 1.07
Nerve sheath myxoma (neurothekeoma) of the skin: light microscopic and immunohistochemical reappraisal of the cellular variant. J Cutan Pathol (1993) 1.07
Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization. Cytogenet Cell Genet (1992) 1.07
Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat Res (1990) 1.05
Osteolytic lesions and bacillary angiomatosis in HIV infection: radiologic differentiation from AIDS-related Kaposi sarcoma. Radiology (1990) 1.05
Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. Am J Pathol (1994) 1.05
Detection of aneuploid human sperm by fluorescence in situ hybridization: evidence for a donor difference in frequency of sperm disomic for chromosomes 1 and Y. Am J Hum Genet (1993) 1.05
Radiation therapy for ocular necrobiotic xanthogranuloma. Arch Ophthalmol (1987) 1.04